Early evidence raises safety questions for osteo‑metabolic health New analyses presented at a major professional meeting indicate a possible association between GLP‑1 receptor agonists and a slightly increased risk of osteoporosis and gout. The signals come from observational research and safety…
Continue reading...
Continue reading...